Key result
Sotalol significantly reduced heart rate, cardiac output, and indices of myocardial function (dp/dt max and V max) in patients with heart disease, while stroke volume remained unchanged.
Why the study?
Does sotalol alter hemodynamics and myocardial function in patients with heart disease?
Observational
Does sotalol alter hemodynamics and myocardial function in patients with heart disease?
Sotalol exerts negative chronotropic and inotropic effects in patients with heart disease, reducing heart rate, cardiac output, and myocardial function indices without altering stroke volume or blood pressure.
Answers are grounded in this paper and cite their sources.
Sotalol warrants hemodynamic caution in heart disease; leaves open net clinical effects in prospective trials.
The cardiovascular effects of the beta-adrenergic blocking agent, sotalol, have been assessed in a group of patients with heart disease. There was a significant reduction in heart rate and cardiac output, but stroke volume was unchanged. Systemic arterial and pulmonary artery pressures were not significantly altered. Indices of mryocardial function (dp/dt max and V max) were also significantly reduced.
No takes yet. Share an insight, caveat, or question.
Hutton et al. (1972) conducted an observational in heart disease. sotalol was evaluated on cardiovascular effects including heart rate, cardiac output, and myocardial function. Sotalol significantly reduced heart rate, cardiac output, and indices of myocardial function (dp/dt max and V max) in patients with heart disease, while stroke volume remained unchanged.
Synapse has enriched 10 related papers. Consider them for comparative context: